Related Experiment Video

Updated: Jul 19, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines

Helga Engi1, Hiroshi Sakagami, Masami Kawase

  • 1Department of Medical Microbiology and Immunobiology, Albert Szent-Györgyi Medical Centre, University of Szeged, H-6720 Szeged, Hungary.

In Vivo (Athens, Greece)
|November 10, 2006
PubMed

Insights

Researchers investigated 41 dihydropyridine derivatives for their ability to inhibit P-glycoprotein, a key factor in multidrug resistance. While many compounds blocked drug efflux, they also showed notable cytotoxicity against cancer and normal cells, with no clear structure-activity relationship.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • P-glycoprotein (P-gp) is a transmembrane efflux pump crucial in multidrug resistance (MDR) of cancer.
  • Inhibiting P-gp is a strategy to overcome MDR and enhance chemotherapy efficacy.
  • 1,4-dihydropyridine derivatives are explored for their potential biological activities.

Purpose of the Study:

  • To evaluate the P-gp inhibitory potential of 41 novel 1,4-diphenyl-1,4-dihydropyridine derivatives.
  • To assess the cytotoxicity of these compounds against multidrug-resistant cancer cells and normal cell lines.
  • To investigate the relationship between chemical structure and MDR reversal or cytotoxic activity.

Main Methods:

  • Flow cytometry was used to measure the inhibition of rhodamine 123 outward transport by P-gp.
  • Cytotoxicity assays were performed on human colon cancer (COLO320) and human mdr1 gene-transfected mouse lymphoma (L 5178 Y) cell lines.
  • Additional cytotoxicity testing was conducted against human oral tumor and normal oral cell lines.

Main Results:

  • Most tested dihydropyridine derivatives effectively inhibited rhodamine 123 efflux, indicating P-gp inhibition.
  • The compounds exhibited non-negligible cytotoxicity against both cancer and normal cell lines.
  • Some derivatives showed cytotoxic effects against oral tumor cell lines, but also against normal oral cells.
  • No clear correlation was found between the chemical structures and the observed MDR reversal or cytotoxic effects.
  • Structural modifications, specifically new ring substituents, were found to prevent the oxidation of the aromatic ring.

Conclusions:

  • 1,4-dihydropyridine derivatives can inhibit P-glycoprotein-mediated drug efflux.
  • The cytotoxic profiles of these compounds necessitate careful evaluation for therapeutic applications due to effects on normal cells.
  • Further research is needed to establish clear structure-activity relationships for optimizing P-gp inhibitors with reduced off-target toxicity.

More Related Videos

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...